Patents by Inventor Peishing Hu

Peishing Hu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination cancer immunotherapy with co-stimulatory molecules
    Patent number: 8268788
    Abstract: Provided are methods of reducing the size of a tumor or inhibiting the growth of cancer cells in an individual or inhibiting the development of metastatic cancer by administering an effective amount of a soluble form of a co-stimulatory molecule from an antigen presenting cell and by reducing the activity of immunoregulatory T cells in the individual. Methods of reduction in the activity of immunoregulatory T cells involve removing them ex vivo or depleting or inactivating them in vivo. Also provided are cancer therapeutic compositions comprising a soluble form of a co-stimulatory molecule from an antigen presenting cell and an antibody specific for an intracellular antigen.
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: September 18, 2012
    Assignee: University of Southern California
    Inventors: Alan Epstein, Peishing Hu
  • Combination cancer immunotherapy with co-stimulatory molecules
    Patent number: 8207130
    Abstract: Provided are methods of reducing the size of a tumor or inhibiting the growth of cancer cells in an individual or inhibiting the development of metastatic cancer by administering an effective amount of a soluble form of a co-stimulatory molecule from an antigen presenting cell and by reducing the activity of immunoregulatory T cells in the individual. Methods of reduction in the activity of immunoregulatory T cells involve removing them ex vivo or depleting or inactivating them in vivo. Also provided are cancer therapeutic compositions comprising a soluble form of a co-stimulatory molecule from an antigen presenting cell and an antibody specific for an intracellular antigen.
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: June 26, 2012
    Assignee: University of Southern California
    Inventors: Alan Epstein, Peishing Hu
  • COMBINATION CANCER IMMUNOTHERAPY WITH CO-STIMULATORY MOLECULES
    Publication number: 20110002920
    Abstract: Provided are methods of reducing the size of a tumor or inhibiting the growth of cancer cells in an individual or inhibiting the development of metastatic cancer by administering an effective amount of a soluble form of a co-stimulatory molecule from an antigen presenting cell and by reducing the activity of immunoregulatory T cells in the individual. Methods of reduction in the activity of immunoregulatory T cells involve removing them ex vivo or depleting or inactivating them in vivo. Also provided are cancer therapeutic compositions comprising a soluble form of a co-stimulatory molecule from an antigen presenting cell and an antibody specific for an intracellular antigen.
    Type: Application
    Filed: March 25, 2010
    Publication date: January 6, 2011
    Inventors: Alan Epstein, Peishing Hu
  • COMBINATION CANCER IMMUNOTHERAPY WITH CO-STIMULATORY MOLECULES
    Publication number: 20110002921
    Abstract: Provided are methods of reducing the size of a tumor or inhibiting the growth of cancer cells in an individual or inhibiting the development of metastatic cancer by administering an effective amount of a soluble form of a co-stimulatory molecule from an antigen presenting cell and by reducing the activity of immunoregulatory T cells in the individual. Methods of reduction in the activity of immunoregulatory T cells involve removing them ex vivo or depleting or inactivating them in vivo. Also provided are cancer therapeutic compositions comprising a soluble form of a co-stimulatory molecule from an antigen presenting cell and an antibody specific for an intracellular antigen.
    Type: Application
    Filed: March 25, 2010
    Publication date: January 6, 2011
    Inventors: Alan Epstein, Peishing Hu
  • Combination cancer immunotherapy with co-stimulatory molecules
    Patent number: 7696175
    Abstract: Provided are methods of reducing the size of a tumor or inhibiting the growth of cancer cells in an individual or inhibiting the development of metastatic cancer by administering an effective amount of a soluble form of a co-stimulatory molecule from an antigen presenting cell and by reducing the activity of immunoregulatory T cells in the individual. Methods of reduction in the activity of immunoregulatory T cells involve removing them ex vivo or depleting or inactivating them in vivo. Also provided are cancer therapeutic compositions comprising a soluble form of a co-stimulatory molecule from an antigen presenting cell and an antibody specific for an intracellular antigen.
    Type: Grant
    Filed: October 28, 2005
    Date of Patent: April 13, 2010
    Assignee: University of Southern California
    Inventors: Alan Epstein, Peishing Hu
  • Combination cancer immunotherapy with co-stimulatory molecules
    Publication number: 20060171949
    Abstract: Provided are methods of reducing the size of a tumor or inhibiting the growth of cancer cells in an individual or inhibiting the development of metastatic cancer by administering an effective amount of a soluble form of a co-stimulatory molecule from an antigen presenting cell and by reducing the activity of immunoregulatory T cells in the individual. Methods of reduction in the activity of immunoregulatory T cells involve removing them ex vivo or depleting or inactivating them in vivo. Also provided are cancer therapeutic compositions comprising a soluble form of a co-stimulatory molecule from an antigen presenting cell and an antibody specific for an intracellular antigen.
    Type: Application
    Filed: October 28, 2005
    Publication date: August 3, 2006
    Inventors: Alan Epstein, Peishing Hu